We aimed to investigate the expression of proteins that might relate to epilepsy—mammalian target of rapamycin (mTOR) and semaphorin 3F (SEMA3F), respectively—for establishing the mechanism and explaining the antiepileptic effect of GR. The gene discussed is MTOR; the disease is epilepsy.